Literature DB >> 4192162

An antigen density effect on the hemolytic efficiency of complement.

W D Linscott.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4192162

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  9 in total

Review 1.  Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects.

Authors:  B P Morgan
Journal:  Biochem J       Date:  1989-11-15       Impact factor: 3.857

2.  The role of blocking antibodies in immunological enhancement.

Authors:  M Takasugi; E Klein
Journal:  Immunology       Date:  1971-10       Impact factor: 7.397

3.  Specificity of rabbit antisera against mouse leukaemias in vitro.

Authors:  A E Reif; C A Kim
Journal:  Immunology       Date:  1971-06       Impact factor: 7.397

4.  Further studies on the biological properties of guinea-pig IgG1 antibodies. III. Haemolytic efficiency in vitro.

Authors:  P Vuagnat
Journal:  Immunology       Date:  1977-01       Impact factor: 7.397

5.  Monoclonal anti-human T-lymphocyte antibodies: enumeration and characterization of T-cell subsets.

Authors:  J Van Wauwe; J Goossens
Journal:  Immunology       Date:  1981-01       Impact factor: 7.397

6.  The significance of erythrocyte antigen site density. II. Hemolysis.

Authors:  L W Hoyer; N C Trabold
Journal:  J Clin Invest       Date:  1971-09       Impact factor: 14.808

7.  Lysis of herpes simplex virus-infected cells early in the infectious cycle by human antiviral antibody and complement.

Authors:  T L Cromeans; S L Shore
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

8.  Experimental Chagas' disease in complement-deficient mice and guinea pigs.

Authors:  A P Dalmasso; J A Jarvinen
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

9.  Mechanisms of tumour cell escape encountered in treating lymphocytic leukaemia with anti-idiotypic antibody.

Authors:  J Gordon; A K Abdul-Ahad; T J Hamblin; F K Stevenson; G T Stevenson
Journal:  Br J Cancer       Date:  1984-05       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.